Calliditas Therapeutics AB Sponsored ADR Debt to Equity Ratio 2020-2024 | CALT
Current and historical debt to equity ratio values for Calliditas Therapeutics AB Sponsored ADR (CALT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Calliditas Therapeutics AB Sponsored ADR debt/equity for the three months ending June 30, 2024 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-06-30 | $0.15B | $0.01B | 15.36 |
| 2024-03-31 | $0.15B | $0.01B | 13.05 |
| 2023-12-31 | $0.14B | $0.03B | 4.55 |
| 2023-09-30 | $0.12B | $0.03B | 3.57 |
| 2023-06-30 | $0.11B | $0.05B | 2.39 |
| 2023-03-31 | $0.12B | $0.06B | 2.04 |
| 2022-12-31 | $0.12B | $0.08B | 1.55 |
| 2022-09-30 | $0.08B | $0.07B | 1.09 |
| 2022-06-30 | $0.08B | $0.07B | 1.02 |
| 2022-03-31 | $0.05B | $0.09B | 0.54 |
| 2021-12-31 | $0.05B | $0.12B | 0.45 |
| 2021-09-30 | $0.06B | $0.15B | 0.37 |
| 2021-06-30 | $0.03B | $0.12B | 0.27 |
| 2021-03-31 | $0.03B | $0.14B | 0.23 |
| 2020-12-31 | $0.03B | $0.14B | 0.20 |
| 2020-09-30 | $0.01B | $0.16B | 0.05 |
| 2020-06-30 | $0.01B | $0.15B | 0.04 |
| 2020-03-31 | $0.01B | $0.08B | 0.08 |
| 2019-12-31 | $0.01B | $0.08B | 0.07 |
| 2019-09-30 | $0.00B | $0.09B | 0.04 |
| 2019-06-30 | $0.01B | $0.07B | 0.07 |
| 2019-03-31 | $0.00B | $0.06B | 0.05 |
